News

Recursion: FDA To Replace Animal Testing With AI? - A Small But Necessary Win
Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...
Raising Our Epiroc Moat Rating to Wide and Our Fair Value Estimate to SEK 188
Our fair value estimate is SEK 188 per share, translating into a 25 times forward multiple on 2025 expected earnings. We forecast 6% annualized earnings per share growth through 2029.
Schindler: Raising Fair Value Estimate by 17%; Modernization Underpins Structural Growth
We view Schindler’s approach to shareholder distributions as broadly appropriate. The company targets a dividend payout ratio of 50% to 80% of earnings. We believe there is scope to increase ...
Committee for a Responsible Federal Budget8h
Senate Instructions Could Add $1.1T in Interest Costs
Congress’ concurrent budget resolution includes reconciliation instructions to allow lawmakers to pass a bill that a ...
Self-Employed and Behind on Taxes? Clear Start Tax Offers Guidance on Getting Back on Track in 2025
From Missed Payments to IRS Notices, Clear Start Tax Helps Freelancers and Small Business Owners Resolve Back Tax Issues and Avoid Costly Penalties ...
Soaring Costs, Banned Lunches, and a Looming Ad Apocalypse: Trump’s Tariffs Hit Hollywood
While some of the import taxes were scaled back on Wednesday just hours after they went into effect, the still-considerable ...